CI
VNDA icon

Cowen Inc’s Vanda Pharmaceuticals VNDA Stock Holding History

Cowen Inc’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-19,725
Closed -$250K – 434
2015
Q2 		$250K Hold
19,725
– – 0.02% 316
2015
Q1 		$183K Buy
19,725
+12,725
+182% +$144K 0.02% 351
2014
Q4 		$0 Sell
7,000
-7,900
-53% -$93.5K ﹤0.01% 298
2014
Q3 		$155K Sell
14,900
-100
-0.7% -$1.31K 0.02% 265
2014
Q2 		$243K Sell
15,000
-15,000
-50% -$200K 0.03% 213
2014
Q1 		$488K Buy
30,000
+5,000
+20% +$71.1K 0.06% 137
2013
Q4 		$310K Buy
+25,000
New +$251K 0.05% 182

Other funds holding VNDA

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cowen Inc's VNDA Position: Q3 2015 in Review

Cowen Inc sold out of Vanda Pharmaceuticals (VNDA) in Q3 2015, closing a stake of 19,725 shares — an estimated $250K sold.

Cowen Inc first reported a position in VNDA in Q4 2013 and held it in 7 quarters. The position peaked at $488K in Q1 2014. 122 funds tracked by Wall St. Rank hold VNDA as of Q3 2015.

  • Cowen Inc reported no remaining Vanda Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Cowen Inc sold 19,725 Vanda Pharmaceuticals shares in Q3 2015, an estimated $250K.
  • Cowen Inc first reported a position in Vanda Pharmaceuticals in Q4 2013 and held it in 7 quarters.
  • Cowen Inc's Vanda Pharmaceuticals position peaked at $488K in Q1 2014.
  • 122 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.